Broadfin Capital’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Hold |
0
| – | – | – | 46 |
|
2019
Q3 | – | Hold |
0
| – | – | – | 47 |
|
2019
Q2 | – | Sell |
-148,100
| Closed | -$10.9M | – | 39 |
|
2019
Q1 | $10.9M | Sell |
148,100
-51,900
| -26% | -$3.8M | 2.24% | 15 |
|
2018
Q4 | $8.48M | Sell |
200,000
-157,672
| -44% | -$6.69M | 1.12% | 22 |
|
2018
Q3 | $16.8M | Sell |
357,672
-662,506
| -65% | -$31.2M | 2.48% | 11 |
|
2018
Q2 | $50.3M | Sell |
1,020,178
-423,770
| -29% | -$20.9M | 7.92% | 2 |
|
2018
Q1 | $44.3M | Sell |
1,443,948
-1,003,798
| -41% | -$30.8M | 6.91% | 2 |
|
2017
Q4 | $44.7M | Sell |
2,447,746
-43,055
| -2% | -$786K | 7.3% | 1 |
|
2017
Q3 | $29.1M | Hold |
2,490,801
| – | – | 4.31% | 9 |
|
2017
Q2 | $9.09M | Buy |
2,490,801
+400,000
| +19% | +$1.46M | 1.1% | 24 |
|
2017
Q1 | $10.9M | Buy |
2,090,801
+1,264,800
| +153% | +$6.58M | 1.32% | 23 |
|
2016
Q4 | $3.92M | Sell |
826,001
-173,999
| -17% | -$827K | 0.44% | 48 |
|
2016
Q3 | $6.61M | Buy |
1,000,000
+306,137
| +44% | +$2.02M | 0.59% | 44 |
|
2016
Q2 | $3.79M | Buy |
693,863
+500,000
| +258% | +$2.73M | 0.37% | 50 |
|
2016
Q1 | $4.15M | Sell |
193,863
-42,007
| -18% | -$899K | 0.4% | 50 |
|
2015
Q4 | $7.45M | Sell |
235,870
-59,830
| -20% | -$1.89M | 0.46% | 52 |
|
2015
Q3 | $10.2M | Sell |
295,700
-63,961
| -18% | -$2.2M | 0.57% | 42 |
|
2015
Q2 | $11.3M | Buy |
359,661
+53,198
| +17% | +$1.67M | 0.61% | 40 |
|
2015
Q1 | $8.99M | Buy |
306,463
+121,707
| +66% | +$3.57M | 0.7% | 38 |
|
2014
Q4 | $3.42M | Hold |
184,756
| – | – | 0.3% | 62 |
|
2014
Q3 | $3.24M | Hold |
184,756
| – | – | 0.34% | 61 |
|
2014
Q2 | $3.7M | Hold |
184,756
| – | – | 0.36% | 56 |
|
2014
Q1 | $3.52M | Sell |
184,756
-29,530
| -14% | -$563K | 0.34% | 66 |
|
2013
Q4 | $3.56M | Buy |
+214,286
| New | +$3.56M | 0.47% | 46 |
|